_:n8160662df3a844ca96da9dc53c77a211xb0
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<https://www.cmlviz.com/stocks/GILD/news/b/2022/08/22/gilead-announces-first-global-regulatory-approval-of-sunlenca-lenacapavir-the-only-twice-yearly-hiv-treatment-option>